Diagnostic Agent Detects Colorectal Cancer Response to Therapy in 1 Day in Mice
A preclinical study showed that response of colorectal cancer to treatment can be detected after a single administration using the diagnostic agent TumorVue (99mTc-duramycin), developed by Molecular Targeting Technologies (MTTI). These ... Read more